Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.35 and traded as high as $9.33. AIkido Pharma shares last traded at $7.58, with a volume of 2,016,839 shares trading hands.
AIkido Pharma Stock Down 3.7 %
The stock’s 50-day moving average price is $3.37 and its 200 day moving average price is $2.35. The company has a market cap of $41.58 million, a P/E ratio of -1.95 and a beta of 0.93.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- 3 REITs to Buy and Hold for the Long Term
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Should You Invest in Penny Stocks?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What Investors Need to Know About Upcoming IPOs
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
